Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Infacol 40mg/ml oral suspension
0101010R0BCAAAB
|
Infacol | Simeticone | Gastro-Intestinal System | 2,237 |
|
Simeticone 100mg capsules
0101010R0AAAAAA
|
Simeticone | Simeticone | Gastro-Intestinal System | 2,234 |
|
Simeticone 40mg/ml oral suspension sugar free
0101010R0AAABAB
|
Simeticone | Simeticone | Gastro-Intestinal System | 886 |
|
Simeticone 125mg capsules
0101010R0AAAHAH
|
Simeticone | Simeticone | Gastro-Intestinal System | 806 |
|
Wind-eze 125mg gel caps
0101010R0BFABAH
|
Wind-eze | Simeticone | Gastro-Intestinal System | 164 |
|
Dentinox Infant colic drops
0101010R0BEAAAD
|
Dentinox (Antacid) | Simeticone | Gastro-Intestinal System | 146 |
|
WindSetlers 100mg capsules
0101010R0BHAAAA
|
WindSetlers | Simeticone | Gastro-Intestinal System | 144 |
|
Simeticone 42mg/5ml oral drops
0101010R0AAADAD
|
Simeticone | Simeticone | Gastro-Intestinal System | 83 |
|
Simeticone 125mg chewable tablets
0101010R0AAAEAE
|
Simeticone | Simeticone | Gastro-Intestinal System | 29 |
|
Wind-eze 125mg chewable tablets
0101010R0BFAAAE
|
Wind-eze | Simeticone | Gastro-Intestinal System | 6 |
|
Asilone Windcheaters 100mg capsules
0101010R0BBAAAA
|
Asilone Windcheater | Simeticone | Gastro-Intestinal System | No data available |
|
Simeticone 66.7mg/ml oral drops sugar free
0101010R0AAAGAG
|
Simeticone | Simeticone | Gastro-Intestinal System | No data available |
|
Woodward's colic drops
0101010R0BGAAAG
|
Woodward's Colic | Simeticone | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.